Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat ...

Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with ...

India has no dearth of bioscience talent, but translating research into real-world health solutions remains a major challenge ...

Nimacimab alone demonstrated 23.5% weight loss, comparable to monlunabant and tirzepatide alone. “This new preclinical study highlights that a truly peripherally-restricted CB1 inhibitor ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new ...

The bipartisan Ensuring Pathways to Innovative Cures Act would encourage medical innovation and R&D, writes Victoria Ford, ...

You may also meet with admissions staff, subject to staff availability. These tours run on most days and are open to anybody thinking of applying for any of our bioscience courses. The University of ...

Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL ...